Cannabis rulemaking was reviewed, including specifics on implementing a patient excise tax exemption at endorsed stores, and a new survey of social equity program applicants.
As the WSLCB Policy and Rules team jettisoned previously planned public engagements to accommodate backlogged work, WSDA staff would review their expanding cannabis programs.
Public health and prevention interests expressed during a closed meeting with WSLCB leaders the previous day were top of mind for board members during the caucus.
WSLCB leaders would meet privately with public health and prevention advocates to hear their perspectives, presenting another opportunity to ask why these events remain hidden.
In his final bill signing, Governor Jay Inslee offered hope Washington would continue to prosper under a supplemental budget with rates of cannabis spending largely the same as 2023.
While the WSLCB Board cancelled all of their meetings for the week, staff would host two focus groups, WSDA prepared a public hearing, and the obscure WIDAC quarterly meeting was up.
In looking at rulemaking implementing definitional and retail medical endorsement changes, various parties were interested in impacts for producing and selling hemp consumables in 502.
Recalling the summer vacation season and policymaking doldrums, only a WSLCB caucus meeting was scheduled and members had already cancelled meetings for the following week.
Members of the public expressed dissatisfaction over the company picked to process social equity grants, adjudication of a patient cooperative dispute, and new cannabis education offerings.
Staff looked ahead to 2024 legislative implementation and outstanding cannabis projects, including a recently submitted petition to ban disposable vapor cartridges.
